98 related articles for article (PubMed ID: 1320265)
1. Structure-activity study of the C-terminal residue of MEN 10207 tachykinin antagonist.
Rovero P; Quartara L; Astolfi M; Patacchini R; Giachetti A; Maggi CA
Peptides; 1992; 13(1):207-8. PubMed ID: 1320265
[TBL] [Abstract][Full Text] [Related]
2. N-terminal truncated analogs of men 10376 as tachykinin NK-2 receptor antagonists.
Quartara L; Patacchini R; Giuliani S; Renzetti AR; Rovero P; Maggi CA
Life Sci; 1992; 51(25):1929-36. PubMed ID: 1333561
[TBL] [Abstract][Full Text] [Related]
3. Role of D-tryptophan for affinity of MEN 10207 tachykinin antagonist at NK2 receptors.
Rovero P; Astolfi M; Renzetti AR; Patacchini R; Giachetti A; Maggi CA
Peptides; 1991; 12(5):1015-8. PubMed ID: 1666180
[TBL] [Abstract][Full Text] [Related]
4. Further evidence for the existence of NK2 tachykinin receptor subtypes.
Patacchini R; Astolfi M; Quartara L; Rovero P; Giachetti A; Maggi CA
Br J Pharmacol; 1991 Sep; 104(1):91-6. PubMed ID: 1664768
[TBL] [Abstract][Full Text] [Related]
5. Role of C-terminal amidation on the biological activity of neurokinin A derivatives with agonist and antagonist properties.
Patacchini R; Quartara L; Rovero P; Goso C; Maggi CA
J Pharmacol Exp Ther; 1993 Jan; 264(1):17-21. PubMed ID: 8380857
[TBL] [Abstract][Full Text] [Related]
6. Tachykinin receptors in rabbit airways--characterization by functional, autoradiographic and binding studies.
Black JL; Diment LM; Alouan LA; Johnson PR; Armour CL; Badgery-Parker T; Burcher E
Br J Pharmacol; 1992 Oct; 107(2):429-36. PubMed ID: 1384914
[TBL] [Abstract][Full Text] [Related]
7. Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins.
Maggi CA; Patacchini R; Eglezos A; Quartara L; Giuliani S; Giachetti A
Br J Pharmacol; 1992 Sep; 107(1):27-33. PubMed ID: 1384907
[TBL] [Abstract][Full Text] [Related]
8. Effect of scyliorhinin I and synthetic scyliorhinin I derivatives at mammalian tachykinin NK1, NK2 and NK3 receptors.
Patacchini R; Quartara L; Rolka K; Zboinska J; Kupryszewski G; Maggi CA
Eur J Pharmacol; 1993 Dec; 250(2):311-6. PubMed ID: 7509285
[TBL] [Abstract][Full Text] [Related]
9. Affinity of R 396, an NK-2 tachykinin receptor antagonist, for NK-2 receptors in preparations from different species.
Maggi CA; Patacchini R; Astolfi M; Rovero P; Giachetti A; Van Giersbergen PL
Neuropeptides; 1992 Jun; 22(2):93-8. PubMed ID: 1328923
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of NK-2 tachykinin receptors in hamster and rabbit smooth muscles.
Maggi CA; Eglezos A; Quartara L; Patacchini R; Giachetti A
Regul Pept; 1992 Jan; 37(2):85-93. PubMed ID: 1311459
[TBL] [Abstract][Full Text] [Related]
11. Tachykinin receptors in the guinea-pig isolated bronchi.
Maggi CA; Patacchini R; Quartara L; Rovero P; Santicioli P
Eur J Pharmacol; 1991 May; 197(2-3):167-74. PubMed ID: 1717290
[TBL] [Abstract][Full Text] [Related]
12. [3H][beta-Ala8]neurokinin A-(4-10): a novel, selective radioligand for the tachykinin NK2 receptor.
Goso C; Astolfi M; Parlani M; Manzini S
Eur J Pharmacol; 1995 Dec; 294(1):239-45. PubMed ID: 8788437
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological activity of NK-2 selective tachykinin antagonists containing D-tryptophan.
Rovero P; Pestellini V; Patacchini R; Giuliani S; Maggi CA; Meli A; Giachetti A
Peptides; 1990; 11(3):619-20. PubMed ID: 2166282
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship study of R396, an NK2 tachykinin antagonist selective for the NK2B receptor subtype.
Rovero P; Astolfi M; Manzini S; Jukic D; Rouissi N; Maggi CA; Regoli D
Neuropeptides; 1992 Nov; 23(3):143-5. PubMed ID: 1335133
[TBL] [Abstract][Full Text] [Related]
15. Facilitatory effects of selective agonists for tachykinin receptors on cholinergic neurotransmission: evidence for species differences.
Belvisi MG; Patacchini R; Barnes PJ; Maggi CA
Br J Pharmacol; 1994 Jan; 111(1):103-10. PubMed ID: 7516799
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors.
Giuliani S; Patacchini R; Barbanti G; Turini D; Rovero P; Quartara L; Giachetti A; Maggi CA
J Pharmacol Exp Ther; 1993 Nov; 267(2):590-5. PubMed ID: 8246132
[TBL] [Abstract][Full Text] [Related]
17. A potent and selective agonist for NK-2 tachykinin receptor.
Rovero P; Pestellini V; Patacchini R; Giuliani S; Santicioli P; Maggi CA; Meli A; Giachetti A
Peptides; 1989; 10(3):593-5. PubMed ID: 2550911
[TBL] [Abstract][Full Text] [Related]
18. A highly selective NK-2 tachykinin receptor antagonist containing D-tryptophan.
Rovero P; Pestellini V; Maggi CA; Patacchini R; Regoli D; Giachetti A
Eur J Pharmacol; 1990 Jan; 175(1):113-5. PubMed ID: 2157594
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity study of neurokinins: antagonists for the neurokinin-2 receptor.
Dion S; Rouissi N; Nantel F; Jukic D; Rhaleb NE; Tousignant C; Télémaque S; Drapeau G; Regoli D; Naline E
Pharmacology; 1990; 41(4):184-94. PubMed ID: 1964226
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of tachykinin NK-2 receptors in rabbit, guinea-pig and human smooth muscles.
Maggi CA; Giuliani S; Patacchini R; Quartara L; Rovero P; Renzetti AR; Mizrahi J; Giachetti A
Neuropeptides; 1992 Nov; 23(3):181-6. PubMed ID: 1335134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
